Enabling healthy ageing: Leopoldina discussion paper recommends shift in focus in research and medicine
Reports and Proceedings
Updates every hour. Last Updated: 29-Jun-2025 23:11 ET (30-Jun-2025 03:11 GMT/UTC)
Ageing is the primary risk factor for cancer, dementia, and cardiovascular diseases. As the understanding of the biology of ageing constantly improves, there are already initial approaches to geroprotection, which seeks to reduce the age-related risk of disease and thus extend healthy lifespan. In a discussion paper published today by the German National Academy of Sciences Leopoldina, the researchers involved recommend a paradigm shift in how research and medicine approach age-related diseases. In the paper “Health-Extending Medicine in an Aging Society – Prospects for Medical Research and Practice” they call for better research into the ageing process, so that medicine can focus on ageing itself – rather than waiting to treat age-related diseases.
What if people could detect cancer and other diseases with the same speed and ease of a pregnancy test or blood glucose meter? Researchers at the Carl R. Woese Institute for Genomic Biology are a step closer to realizing this goal by integrating machine learning-based analysis into point-of-care biosensing technologies.
The new method, dubbed LOCA-PRAM, was reported in the journal Biosensors and Bioelectronics and improves the accessibility of biomarker detection by eliminating the need for technical experts to perform the image analysis.
Researchers at Karolinska Institutet and Lund University in Sweden have identified a new treatment strategy for neuroblastoma, an aggressive form of childhood cancer. By combining two antioxidant enzyme inhibitors, they have converted cancer cells in mice into healthy nerve cells. The study is published in the journal Proceedings of the National Academy of Sciences (PNAS).
Highlight box
Key findings
• In this study, we have found that the respiratory phase affects the three-dimensional quantitative parameters of pulmonary subsolid nodules (SSNs) in low-dose computed tomography (LDCT) screening, with varying impacts on different types of pulmonary SSNs.
What is known and what is new?
• Previous studies have shown that the degree of lung inflation, reflecting the change of lung volume, could affect the volume and density of pulmonary nodules.
• Our study found that the respiratory phase had the greatest effect on the volume of pulmonary SSNs and the least effect on the long axis diameter in LDCT screening. Most quantitative parameters of pure ground-glass nodules (pGGNs) were more susceptible to respiratory phase than those of part-solid nodules (PSNs).
What is the implication, and what should change now?
• During follow-up, LDCT scan in different respiratory phases may interfere with the judgment of the growth of pulmonary SSNs. The influence of respiratory phase should be fully considered when comparing the changes of SSNs volume in follow-up of LDCT scan.
Three exceptional young clinicians with novel approaches to fighting cancer have been named the 2025 recipients of the Damon Runyon Physician-Scientist Training Award.
Dana-Farber Cancer Institute is launching Direct Connect for Firefighters, a specialized cancer navigation initiative to meet the unique needs of firefighters—a group at higher risk for cancer due to occupational hazards. The program will now be offered to firefighter organizations around the country, expanding Dana-Farber’s existing Direct Connect program.